EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Inhibition of mouse placental lactogen-II release from placental cells by interleukin-1 after mid-pregnancy



Inhibition of mouse placental lactogen-II release from placental cells by interleukin-1 after mid-pregnancy



Journal of Endocrinology 147(3): 423-429



The effects of interleukin (IL-1) and granulocyte-macrophage colony stimulating factor (GM-CSF), which are present in the mouse placenta, on the secretion of mouse placental lactogen (mPL)-I and mPL-II by placental cells were tested in vitro. IL-1-alpha and IL-1-beta, 2.5 nmol/l each, significantly inhibited mPL-II secretion by cells from days 9 and 12 of pregnancy, but did not affect mPL-II secretion by cells from day 7 of pregnancy or mPL-I secretion by cells from days 7, 9 or 12 or pregnancy. GM-CSF had no effect on mPL-I and mPL-II secretion by cells from days 7, 9 or 12 of pregnancy. The inhibitory effects of IL-1-alpha and IL-1-beta on mPL-II secretion were completely eliminated by the addition of antibodies to IL-1-alpha and IL-1-beta respectively. Western blot analysis for mPL-II indicated that IL-1-alpha significantly reduced the intensity of the mPL-II band. Steady-state levels of mPL-II mRNA, assessed by Northern blot analysis, were reduced by incubation of placental cells from day 12 of pregnancy with 2.5 nmol/l IL-1-alpha for 5 days. Co-incubation of 0.25 pmol/l IL-1-alpha, 25 pmol/l IL-6, and 25 pmol/l tumor necrosis factor-alpha, each of which did not significantly inhibit mPL-II secretion by itself, together inhibited mPL-II secretion. These results suggest that IL-1, but not GM-CSF, is a potent inhibitor of mPL-II secretion after mid-pregnancy, and that the combined action of cytokines can inhibit mPL-II secretion.

(PDF same-day service: $19.90)

Accession: 002874174

Download citation: RISBibTeXText

PMID: 8543912

DOI: 10.1677/joe.0.1470423



Related references

Interleukin 6 inhibits mouse placental lactogen II but not mouse placental lactogen I secretion in vitro. Proceedings of the National Academy of Sciences of the United States of America 90(24): 11905-11909, 1994

Interleukin 6 inhibits mouse placental lactogen II but not mouse placental lactogen I secretion in vitro. Proceedings of the National Academy of Sciences of the United States of America 90(24): 11905-9, 1993

Cyclic amp stimulates the acute synthesis and release of human placental lactogen from trophoblast cells evidence for multiple second messengers in human placental lactogen release. Clinical Research 35(3): 584A, 1987

High density lipoproteins stimulate placental lactogen release and adenosine 3',5'-monophosphate (cAMP) production in human trophoblast cells: evidence for cAMP as a second messenger in human placental lactogen release. Endocrinology 123(4): 1879-1884, 1988

High density lipoproteins stimulate placental lactogen release and cyclic amp production in human trophoblast cells evidence for cyclic amp as a second messenger in human placental lactogen release. Endocrinology 123(4): 1879-1884, 1988

Epidermal growth factor stimulates mouse placental lactogen I but inhibits mouse placental lactogen II secretion in vitro. Proceedings of the National Academy of Sciences of the United States of America 89(23): 11396-11400, 1992

Serum placental lactogen in late pregnancy and its relation to placental villous surface and to placental maturation. Zeitschrift für Geburtshilfe und Perinatologie 179(2): 132-138, 1975

Modulation of mouse placental lactogen-I secretion in vitro: effects of progesterone and mouse placental lactogen-II. Endocrinology 130(5): 2897-2905, 1992

Arachidonic acid stimulates phosphoinositide hydrolysis and human placental lactogen release in an enriched fraction of placental cells. Molecular Pharmacology 28(6): 549-554, 1985

Immuno peroxidase localization of human placental lactogen a marker for the placental origin of the giant cells in syncytial endometritis of pregnancy. Journal of Clinical Pathology (London) 34(3): 303-307, 1981

Sn-1,2-diacylglycerols and phorbol esters stimulate the synthesis and release of human placental lactogen from placental cells: a role for protein kinase C. Endocrinology 119(3): 1239-1244, 1986

Co-localization of placental lactogen-I, placental lactogen-II, and proliferin in the mouse placenta at midpregnancy. Biology of Reproduction 51(6): 1188-1192, 1994

A prospective study of 3 biochemical feto placental tests serum human placental lactogen pregnancy specific beta 1 glyco protein and urinary estrogens and their relationship to placental insufficiency. American Journal of Obstetrics & Gynecology 147(4): 430-436, 1983

Transplantable rat choriocarcinoma cells express placental lactogen: identification of placental lactogen-I immunoreactive protein and messenger ribonucleic acid. Endocrinology 127(6): 3131-3137, 1990